Literature DB >> 16527702

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Hashem B El-Serag1, Howard Hampel, Fariba Javadi.   

Abstract

BACKGROUND & AIMS: We conducted a systematic review and a meta-analysis to estimate the magnitude and determinants of association between diabetes and hepatocellular carcinoma (HCC).
METHODS: MEDLINE searches were conducted for published full studies (between January 1966 and February 2005) that provided risk estimates and met criteria concerning the definition of exposure and outcomes. Two investigators independently performed standardized search and data abstraction. Unadjusted and adjusted odds ratios for individual outcomes were obtained or calculated for each study and were synthesized using a random-effects model.
RESULTS: A total of 26 studies met our inclusion and exclusion criteria. Among 13 case-control studies, diabetes was associated significantly with HCC in 9 studies (pooled odds ratio, 2.5; 95% confidence interval, 1.8-3.5). Among 13 cohort studies, diabetes was associated significantly with HCC in 7 studies (pooled risk ratio, 2.5; 95% confidence interval, 1.9-3.2). The results were relatively consistent in different populations, different geographic locations, and a variety of control groups. The significant association between HCC and diabetes was independent of alcohol use or viral hepatitis in the 10 studies that examined these factors. Few studies adjusted for diet and obesity.
CONCLUSIONS: Diabetes is associated with an increased risk for HCC. However, more research is required to examine issues related to the duration and treatment of diabetes, and confounding by diet and obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16527702     DOI: 10.1016/j.cgh.2005.12.007

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  265 in total

1.  Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006.

Authors:  Corinne E Joshu; Anna E Prizment; Paul J Dluzniewski; Andy Menke; Aaron R Folsom; Josef Coresh; Hsin C Yeh; Frederick L Brancati; Elizabeth A Platz; Elizabeth Selvin
Journal:  Int J Cancer       Date:  2012-02-10       Impact factor: 7.396

Review 2.  Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Authors:  Ying Jiang; Qiwen Ben; Hong Shen; Weiqi Lu; Yong Zhang; Jun Zhu
Journal:  Eur J Epidemiol       Date:  2011-09-22       Impact factor: 8.082

3.  Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies.

Authors:  S C Larsson; A Wolk
Journal:  Diabetologia       Date:  2011-01-28       Impact factor: 10.122

4.  Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.

Authors:  Neal D Freedman; Amanda J Cross; Katherine A McGlynn; Christian C Abnet; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; James E Everhart; Rashmi Sinha
Journal:  J Natl Cancer Inst       Date:  2010-08-20       Impact factor: 13.506

Review 5.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Type 2 diabetes mellitus and CA 19-9 levels.

Authors:  Oya Uygur-Bayramicli; Resat Dabak; Ekrem Orbay; Can Dolapcioglu; Mehmet Sargin; Gamze Kilicoglu; Yuksel Guleryuzlu; Alpaslan Mayadagli
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

7.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

8.  Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Authors:  Tsuyoshi Ishikawa; Shogo Shiratsuki; Takashi Matsuda; Takuya Iwamoto; Taro Takami; Koichi Uchida; Shuji Terai; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2013-10-05       Impact factor: 7.527

9.  Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.

Authors:  Erikka Loftfield; Neal D Freedman; Gabriel Y Lai; Stephanie J Weinstein; Katherine A McGlynn; Philip R Taylor; Satu Männistö; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Prev Res (Phila)       Date:  2016-08-29

10.  Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Authors:  Ju Dong Yang; Hager Amed Mohamed; Jessica L Cvinar; Gregory J Gores; Lewis R Roberts; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.